Last reviewed · How we verify
Nutritional Specialties, Inc. — Portfolio Competitive Intelligence Brief
2 marketed
0 filed
0 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Digestive Enzyme Liquescence | PAPAIN | marketed | Non-Standardized Food Allergenic Extract [EPC] | Pain | ||
| Pancreas Liquescence | CHROMIUM | marketed | Standardized Chemical Allergen [EPC] | Metabolic |
Therapeutic area mix
- Metabolic · 1
- Pain · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- · 2 shared drug classes
- University of Guadalajara · 2 shared drug classes
- Deseret Biologicals, Inc. · 1 shared drug class
- Dr. Laurence Klotz · 1 shared drug class
- Energique, Inc. · 1 shared drug class
- Forces of Nature · 1 shared drug class
- Historical Remedies LLP · 1 shared drug class
- Donat R. Spahn · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Nutritional Specialties, Inc.:
- Nutritional Specialties, Inc. pipeline updates — RSS
- Nutritional Specialties, Inc. pipeline updates — Atom
- Nutritional Specialties, Inc. pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Nutritional Specialties, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/nutritional-specialties-inc. Accessed 2026-06-10.